0
Department of Health and Human Services Awarded a Contract to KAIVA STRATEGIES, LLC for $9,594,482.00
Signed on
9/5/2023, 12:00 AM
KAIVA STRATEGIES, LLC Government Contract #75F40123C00073
KAIVA STRATEGIES, LLC was awarded a contract with the United States Government for $9,594,482.00. The contract was awarded by the agency office FDA OFFICE OF ACQ GRANT SVCS, which is a division with the Food and Drug Administration within the Department of Health and Human Services.
Summary of Award
The US federal government awarded a definitive contract with a total obligation of $9,594,482 to Kaiva Strategies, LLC for writer/editor support services for the Center for Drug Evaluation and Research (CDER) Office of New Drugs (OND). The contract was signed on September 5, 2023, and the notice to proceed was issued on May 30. The contract includes labor hour awards for professional services related to policy review and development.
Kaiva Strategies, LLC is a small business based in Ivins, Utah, and is classified as a Category Business, Limited Liability Corporation, Minority Owned Business, Native American Owned Business, SBA Certified 8(a) Joint Venture, Self-Certified Small Disadvantaged Business, Tribally Owned Firm, and U.S.-Owned Business. The company's address is 6060 W 3650 N, Ste 1000, Ivins, UT 84738.
The contract falls under the Department of Health and Human Services, specifically the Food and Drug Administration (FDA), with the period of performance starting on September 5, 2023, and ending on April 4, 2025. The recipient UEI for Kaiva Strategies, LLC is HCWKVFGBPA64.
The contract is for support services in the professional, administrative, and management category, specifically for policy review and development. The product or service code is R406, and the NAICS code is 541690, which corresponds to Other Scientific and Technical Consulting Services.
The contract was awarded through an 8(a) sole source set-aside, with only one offer received and a limited extent of competition. The contract is not subject to the Clinger-Cohen Act planning, labor standards, or construction wage rate requirements. Cost or pricing data was not obtained and was waived for this contract.
The place of performance for the contract is in Rockville, Maryland, with a total outlay of $6,969,965.99. The contract is structured as a labor hours type of contract pricing, and it is not a multi-year contract or a consolidated contract.
Overall, the awarded contract between the US federal government and Kaiva Strategies, LLC for writer/editor support services for the CDER OND demonstrates a strategic partnership with a small business to provide essential services for the FDA's drug evaluation and research efforts.
Contract Details
Agency Details
Recipient Details
Comments
Award Transactions
Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $0.00 to KAIVA STRATEGIES, LLC. The payment included a Subsidy Cost of $0.00.
This payment could indicate a change to the existing contract.
Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $0.00 to KAIVA STRATEGIES, LLC. The payment included a Subsidy Cost of $0.00.
This payment could indicate a change to the existing contract.
Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $0.00 to KAIVA STRATEGIES, LLC. The payment included a Subsidy Cost of $0.00.
This payment could indicate a change to the existing contract.
Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $0.00 to KAIVA STRATEGIES, LLC. The payment included a Subsidy Cost of $0.00.
This payment could indicate a change to the existing contract.
Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $2,239,502.40 to KAIVA STRATEGIES, LLC. The payment included a Subsidy Cost of $0.00.
Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $0.00 to KAIVA STRATEGIES, LLC. The payment included a Subsidy Cost of $0.00.
This payment could indicate a change to the existing contract.
Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $4,917,439.00 to KAIVA STRATEGIES, LLC. The payment included a Subsidy Cost of $0.00.
Food and Drug Administration, a sub agency of Department of Health and Human Services, issued a payment of $2,437,540.60 to KAIVA STRATEGIES, LLC. The payment included a Subsidy Cost of $0.00.